← All organizations
Highest phase reached
Phase 2
First clinical trial
Nov 1, 2016Last known activity
Apr 30, 2022
Acquired by Enliven Therapeutics on Oct 14, 2022
Timeline
2010s
- Jun 1, 2016
Imara, Inc.— Founded
2020s
- Oct 14, 2022
Enliven Therapeutics— Acquired By
Drugs by trial phase (1 distinct, 6 trials)
Phase 2 (1 own, 0 via acquisition)
Indications
Recent trials (7)
- NCT05312021Lead sponsorPhase 2Apr 30, 2022
- NCT04474314Lead sponsorPhase 2Aug 13, 2020
- NCT04474314Study directorPhase 2Aug 13, 2020
- NCT04411082Lead sponsorPhase 2Jun 30, 2020
- NCT04053803Lead sponsorPhase 2May 22, 2019
- NCT03401112Lead sponsorPhase 2Jan 26, 2018
- NCT02998450Lead sponsorPhase 1Nov 1, 2016
Details
- Founded
- Cambridge, MA, US Jun 1, 2016
- Last known activity
- Apr 30, 2022